ARTV
Price
$4.78
Change
+$0.18 (+3.91%)
Updated
Jan 14 closing price
Capitalization
118.06M
74 days until earnings call
Intraday BUY SELL Signals
RANI
Price
$1.40
Change
-$0.02 (-1.41%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
136.57M
69 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARTV vs RANI

Header iconARTV vs RANI Comparison
Open Charts ARTV vs RANIBanner chart's image
Artiva Biotherapeutics
Price$4.78
Change+$0.18 (+3.91%)
Volume$160.1K
Capitalization118.06M
Rani Therapeutics Holdings
Price$1.40
Change-$0.02 (-1.41%)
Volume$5.78K
Capitalization136.57M
ARTV vs RANI Comparison Chart in %
ARTV
Daily Signal:
Gain/Loss:
RANI
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ARTV vs. RANI commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTV is a Hold and RANI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (ARTV: $4.78 vs. RANI: $1.40)
Brand notoriety: ARTV and RANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTV: 12% vs. RANI: 45%
Market capitalization -- ARTV: $118.06M vs. RANI: $136.57M
ARTV [@Biotechnology] is valued at $118.06M. RANI’s [@Biotechnology] market capitalization is $136.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTV’s FA Score shows that 1 FA rating(s) are green whileRANI’s FA Score has 0 green FA rating(s).

  • ARTV’s FA Score: 1 green, 4 red.
  • RANI’s FA Score: 0 green, 5 red.
According to our system of comparison, both ARTV and RANI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTV’s TA Score shows that 5 TA indicator(s) are bullish while RANI’s TA Score has 5 bullish TA indicator(s).

  • ARTV’s TA Score: 5 bullish, 5 bearish.
  • RANI’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RANI is a better buy in the short-term than ARTV.

Price Growth

ARTV (@Biotechnology) experienced а +3.91% price change this week, while RANI (@Biotechnology) price change was +0.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

ARTV is expected to report earnings on Mar 30, 2026.

RANI is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RANI($137M) has a higher market cap than ARTV($118M). ARTV YTD gains are higher at: 11.422 vs. RANI (5.185). RANI has higher annual earnings (EBITDA): -42.95M vs. ARTV (-83.6M). ARTV has more cash in the bank: 123M vs. RANI (4.14M). ARTV has less debt than RANI: ARTV (11.7M) vs RANI (17.6M). RANI has higher revenues than ARTV: RANI (1.2M) vs ARTV (0).
ARTVRANIARTV / RANI
Capitalization118M137M86%
EBITDA-83.6M-42.95M195%
Gain YTD11.4225.185220%
P/E RatioN/AN/A-
Revenue01.2M-
Total Cash123M4.14M2,968%
Total Debt11.7M17.6M66%
TECHNICAL ANALYSIS
Technical Analysis
ARTVRANI
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ARTV
Daily Signal:
Gain/Loss:
RANI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OMVKY14.490.18
+1.26%
OMV AG
AGMJF14.10N/A
N/A
Algoma Central Corp.
GLBKF0.25N/A
N/A
Goldbank Mining Corp.
IHCPF9.80N/A
N/A
Inchcape PLC
DCTIF0.03N/A
N/A
REGENERA INSIGHTS INC.

ARTV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTV has been loosely correlated with KZR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ARTV jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTV
1D Price
Change %
ARTV100%
+3.91%
KZR - ARTV
43%
Loosely correlated
-0.64%
IRON - ARTV
41%
Loosely correlated
+2.17%
RANI - ARTV
40%
Loosely correlated
-1.41%
CELC - ARTV
34%
Loosely correlated
+9.86%
RADX - ARTV
33%
Poorly correlated
+0.58%
More

RANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, RANI has been loosely correlated with KZR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RANI jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RANI
1D Price
Change %
RANI100%
-4.70%
KZR - RANI
55%
Loosely correlated
+1.14%
IRON - RANI
40%
Loosely correlated
-4.53%
ARTV - RANI
40%
Loosely correlated
-5.74%
ACHV - RANI
33%
Loosely correlated
-2.47%
VYGR - RANI
32%
Poorly correlated
+3.08%
More